vs
Kiniksa Pharmaceuticals International, plc（KNSA）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
世纪互联的季度营收约是Kiniksa Pharmaceuticals International, plc的1.8倍（$362.7M vs $202.1M），Kiniksa Pharmaceuticals International, plc净利率更高（7.0% vs -10.7%，领先17.7%），Kiniksa Pharmaceuticals International, plc自由现金流更多（$53.3M vs $-193.1M），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs 17.4%）
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
KNSA vs VNET — 直观对比
营收规模更大
VNET
是对方的1.8倍
$202.1M
净利率更高
KNSA
高出17.7%
-10.7%
自由现金流更多
KNSA
多$246.3M
$-193.1M
两年增速更快
KNSA
近两年复合增速
17.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $362.7M |
| 净利润 | $14.2M | $-38.7M |
| 毛利率 | 89.6% | 20.9% |
| 营业利润率 | 9.8% | 0.5% |
| 净利率 | 7.0% | -10.7% |
| 营收同比 | 65.0% | — |
| 净利润同比 | 259.8% | — |
| 每股收益（稀释后） | $0.18 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KNSAVNET
| Q4 25 | $202.1M | — | ||
| Q3 25 | $180.9M | $362.7M | ||
| Q2 25 | $156.8M | — | ||
| Q1 25 | $137.8M | $309.5M | ||
| Q4 24 | $122.5M | — | ||
| Q3 24 | $112.2M | $302.2M | ||
| Q2 24 | $108.6M | $274.4M | ||
| Q1 24 | $79.9M | $262.9M |
净利润KNSAVNET
| Q4 25 | $14.2M | — | ||
| Q3 25 | $18.4M | $-38.7M | ||
| Q2 25 | $17.8M | — | ||
| Q1 25 | $8.5M | $-2.4M | ||
| Q4 24 | $-8.9M | — | ||
| Q3 24 | $-12.7M | $-2.1M | ||
| Q2 24 | $-3.9M | $-1.1M | ||
| Q1 24 | $-17.7M | $-22.0M |
毛利率KNSAVNET
| Q4 25 | 89.6% | — | ||
| Q3 25 | 88.8% | 20.9% | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.0% | 25.2% | ||
| Q4 24 | 85.4% | — | ||
| Q3 24 | 82.1% | 23.2% | ||
| Q2 24 | 88.7% | 21.3% | ||
| Q1 24 | 86.7% | 21.6% |
营业利润率KNSAVNET
| Q4 25 | 9.8% | — | ||
| Q3 25 | 13.3% | 0.5% | ||
| Q2 25 | 12.9% | — | ||
| Q1 25 | 9.6% | 0.1% | ||
| Q4 24 | -15.7% | — | ||
| Q3 24 | -8.6% | 24.5% | ||
| Q2 24 | -0.1% | 0.2% | ||
| Q1 24 | -20.7% | 0.2% |
净利率KNSAVNET
| Q4 25 | 7.0% | — | ||
| Q3 25 | 10.2% | -10.7% | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 6.2% | -0.8% | ||
| Q4 24 | -7.3% | — | ||
| Q3 24 | -11.3% | -0.7% | ||
| Q2 24 | -3.6% | -0.4% | ||
| Q1 24 | -22.2% | -8.4% |
每股收益（稀释后）KNSAVNET
| Q4 25 | $0.18 | — | ||
| Q3 25 | $0.23 | — | ||
| Q2 25 | $0.23 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.18 | — | ||
| Q2 24 | $-0.06 | — | ||
| Q1 24 | $-0.25 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $414.1M | $492.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $567.6M | $890.8M |
| 总资产 | $763.6M | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KNSAVNET
| Q4 25 | $414.1M | — | ||
| Q3 25 | $352.1M | $492.1M | ||
| Q2 25 | $307.8M | — | ||
| Q1 25 | $268.3M | $544.3M | ||
| Q4 24 | $243.6M | — | ||
| Q3 24 | $223.8M | $219.5M | ||
| Q2 24 | $218.8M | $247.2M | ||
| Q1 24 | $213.6M | $246.9M |
总债务KNSAVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KNSAVNET
| Q4 25 | $567.6M | — | ||
| Q3 25 | $535.4M | $890.8M | ||
| Q2 25 | $495.0M | — | ||
| Q1 25 | $457.5M | $927.8M | ||
| Q4 24 | $438.4M | — | ||
| Q3 24 | $437.0M | $902.9M | ||
| Q2 24 | $435.1M | $900.6M | ||
| Q1 24 | $431.9M | $895.1M |
总资产KNSAVNET
| Q4 25 | $763.6M | — | ||
| Q3 25 | $712.3M | $6.1B | ||
| Q2 25 | $661.1M | — | ||
| Q1 25 | $599.3M | $5.4B | ||
| Q4 24 | $580.6M | — | ||
| Q3 24 | $555.3M | $4.3B | ||
| Q2 24 | $542.4M | $4.0B | ||
| Q1 24 | $519.7M | $3.9B |
负债/权益比KNSAVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.9M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $53.3M | $-193.1M |
| 自由现金流率自由现金流/营收 | 26.4% | -53.2% |
| 资本支出强度资本支出/营收 | 0.3% | 84.6% |
| 现金转化率经营现金流/净利润 | 3.80× | — |
| 过去12个月自由现金流最近4个季度 | $136.4M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流KNSAVNET
| Q4 25 | $53.9M | — | ||
| Q3 25 | $33.7M | $113.8M | ||
| Q2 25 | $28.1M | — | ||
| Q1 25 | $22.3M | $27.0M | ||
| Q4 24 | $18.8M | — | ||
| Q3 24 | $-2.2M | $108.3M | ||
| Q2 24 | $5.2M | $55.8M | ||
| Q1 24 | $4.0M | $37.1M |
自由现金流KNSAVNET
| Q4 25 | $53.3M | — | ||
| Q3 25 | $33.0M | $-193.1M | ||
| Q2 25 | $27.9M | — | ||
| Q1 25 | $22.2M | $-220.0M | ||
| Q4 24 | $18.6M | — | ||
| Q3 24 | — | $-95.0M | ||
| Q2 24 | — | $-81.6M | ||
| Q1 24 | $3.9M | $-102.2M |
自由现金流率KNSAVNET
| Q4 25 | 26.4% | — | ||
| Q3 25 | 18.2% | -53.2% | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 16.1% | -71.1% | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | — | -31.4% | ||
| Q2 24 | — | -29.8% | ||
| Q1 24 | 4.9% | -38.9% |
资本支出强度KNSAVNET
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.4% | 84.6% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | 79.8% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.0% | 67.3% | ||
| Q2 24 | 0.0% | 50.1% | ||
| Q1 24 | 0.1% | 53.0% |
现金转化率KNSAVNET
| Q4 25 | 3.80× | — | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 2.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
